Wen, P. Y., Rodon Ahnert, J., Mason, W., Beck, J. T., DeGroot, J., & Donnet, V. (2020). Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Citación estilo ChicagoWen, Patrick Yung, Jordi Rodon Ahnert, Warren Mason, Joseph T. Beck, John DeGroot, y Valerie Donnet. Phase I, Open-label, Multicentre Study of Buparlisib in Combination With Temozolomide or With Concomitant Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma. 2020.
Cita MLAWen, Patrick Yung, et al. Phase I, Open-label, Multicentre Study of Buparlisib in Combination With Temozolomide or With Concomitant Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma. 2020.